![1]() - Opinion- Guideline: Diagnosis and treatment of adults with community-acquired pneumonia- November 22, 2019- The practice guideline was jointly written by an ad hoc committee of the American Thoracic Society and Infectious Diseases Society of America. 
![1]() - News- Geriatric IBD hospitalization carries steep inpatient mortality- November 21, 2019- SAN ANTONIO – A major unmet need exists for better guideline-directed management of geriatric patients hospitalized for IBD. 
- News- Hyperkalemia-related treatment changes linked to death in acute HF- November 21, 2019- It’s not the potassium, but the subsequent dosage reduction, that may boost mortality after hospitalization for acute heart failure. 
![1]() - News- Apps for busy pediatric hospitalists 2.0- November 21, 2019- Online software tools allow for easy collaboration. 
![1]() - News- Findings confirm link between methimazole and risk for acute pancreatitis- November 21, 2019- CHICAGO – However, there is no evidence of a cumulative dose effect. 
![1]() - News- Ask about vaping in patients with respiratory symptoms, CDC says- November 20, 2019- New CDC recommendations intended to help HCPs pinpoint and manage vaping-associated lung injuries as seasonal respiratory infections trend upward. 
![1]() - News- Documentation tips: Acute respiratory failure- November 20, 2019- Documenting acute respiratory failure accurately matters, regardless if it is, or is not, the primary diagnosis. 
![1]() - News- Pulmonary embolism treatment teams adopted widely for complex disease- November 20, 2019- NEW YORK – The challenge of pulmonary embolism is being increasingly addressed with dedicated teams. 
![1]() - News- Treatment of recurrent C. difficile infection- November 18, 2019- Guidelines strongly recommend fecal microbiota transplantation for patients who have recurrences. 
![1]() - Article- FDA approves cefiderocol for multidrug-resistant, complicated urinary tract infections- November 15, 2019- The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate. 








